AD patients exhibit increased concentrations of Tau and, limited to the initial phase, of Aβ oligomers in the CSF, which indicates that pathogenic aggregates are released from cells into the extracellular space (ECS) [123,124,125]. The gene discussed is MAPT; the disease is Alzheimer disease.